|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin ZZ, Shau WY, Hsu C, Shao YY, Yeh YC,
Kuo RN, Hsu CH, Yang JC, Cheng AL and Lai MS: Radiofrequency
ablation is superior to ethanol injection in early-stage
hepatocellular carcinoma irrespective of tumor size. PloS One.
8:e802762013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lazarevich NL, Cheremnova OA, Varga EV,
Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, Fleishman DI,
Engelhardt NV and Duncan S: Progression of HCC in mice is
associated with a downregulation in the expression of hepatocyte
nuclear factors. Hepatology. 39:1038–1047. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hashiguchi M, Ueno S, Sakoda M, Iino S,
Hiwatashi K, Minami K, Ando K, Mataki Y, Maemura K, Shinchi H, et
al: Clinical implication of ZEB-1 and E-cadherin expression in
hepatocellular carcinoma (HCC). BMC Cancer. 13:5722013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zeisel SH: Choline deficiency. J Nutr
Biochem. 1:332–349. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anderson OS, Sant KE and Dolinoy DC:
Nutrition and epigenetics: An interplay of dietary methyl donors,
one-carbon metabolism and DNA methylation. J Nutr Biochem.
23:853–859. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iorio E, Mezzanzanica D, Alberti P,
Spadaro F, Ramoni C, D'Ascenzo S, Millimaggi D, Pavan A, Dolo V,
Canevari S and Podo F: Alterations of choline phospholipid
metabolism in ovarian tumor progression. Cancer Res. 65:9369–9376.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Michel V, Yuan Z, Ramsubir S and Bakovic
M: Choline transport for phospholipid synthesis. Exp Biol Med
(Maywood). 231:490–504. 2006.
|
|
9
|
O'Regan S, Traiffort E, Ruat M, Cha N,
Compaore D and Meunier FM: An electric lobe suppressor for a yeast
choline transport mutation belongs to a new family of
transporter-like proteins. Proc Natl Acad Sci USA. 97:1835–1840.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Machová E, O'Regan S, Newcombe J, Meunier
FM, Prentice J, Dove R, Lisá V and Dolezal V: Detection of choline
transporter-like 1 protein CTL1 in neuroblastoma × glioma cells and
in the CNS, and its role in choline uptake. J Neurochem.
110:1297–1309. 2009. View Article : Google Scholar
|
|
11
|
Kommareddi PK, Nair TS, Thang LV, Galano
MM, Babu E, Ganapathy V, Kanazawa T, McHugh JB and Carey TE:
Isoforms, expression, glycosylation and tissue distribution of
CTL2/SLC44A2. Protein J. 29:417–426. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Traiffort E, Ruat M, O'Regan S and Meunier
FM: Molecular characterization of the family of choline
transporter-like proteins and their splice variants. J Neurochem.
92:1116–1125. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shephard DA: The 1975 Declaration of
Helsinki and consent. Can Med Assoc J. 115:1191–1192.
1976.PubMed/NCBI
|
|
14
|
Kunter I, Erdal E, Nart D, Yilmaz F,
Karademir S, Sagol O and Atabey N: Active form of AKT controls cell
proliferation and response to apoptosis in hepatocellular
carcinoma. Oncol Rep. 31:573–580. 2014.
|
|
15
|
Hong X, Song R, Song H, Zheng T, Wang J,
Liang Y, Qi S, Lu Z, Song X, Jiang H, et al: PTEN antagonises
Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to
hepatocarcinogenesis. Gut. 63:1635–1647. 2014. View Article : Google Scholar
|
|
16
|
Inazu M: Choline transporter-like proteins
CTLs/SLC44 family as a novel molecular target for cancer therapy.
Biopharm Drug Dispos. 35:431–449. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Inazu M, Yamada T, Kubota N and Yamanaka
T: Functional expression of choline transporter-like protein 1
(CTL1) in small cell lung carcinoma cells: A target molecule for
lung cancer therapy. Pharmacol Res. 76:119–131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang T, Li J, Chen F, Zhao Y, He X, Wan D
and Gu J: Choline transporters in human lung adenocarcinoma:
Expression and functional implications. Acta Bioch Bioph Sin
(Shanghai). 39:668–674. 2007. View Article : Google Scholar
|
|
19
|
Awwad HM, Geisel J and Obeid R: The role
of choline in prostate cancer. Clin Biochem. 45:1548–1553. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kouji H, Inazu M, Yamada T, Tajima H, Aoki
T and Matsumiya T: Molecular and functional characterization of
choline transporter in human colon carcinoma HT-29 cells. Arch
Biochem Biophys. 483:90–98. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Inazu M, Takeda H and Matsumiya T:
Molecular and functional characterization of an Na+-independent
choline transporter in rat astrocytes. J Neurochem. 94:1427–1437.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yabuki M, Inazu M, Yamada T, Tajima H and
Matsumiya T: Molecular and functional characterization of choline
transporter in rat renal tubule epithelial NRK-52E cells. Arch
Biochem Biophys. 485:88–96. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang S, Bian C, Yang Z, Bo Y, Li J, Zeng
L, Zhou H and Zhao RC: miR-145 inhibits breast cancer cell growth
through RTKN. Int J Oncol. 34:1461–1466. 2009.PubMed/NCBI
|
|
24
|
Sevli S, Uzumcu A, Solak M, Ittmann M and
Ozen M: The function of microRNAs, small but potent molecules, in
human prostate cancer. Prostate Cancer Prostatic Dis. 13:208–217.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Malumbres M and Barbacid M: Mammalian
cyclin-dependent kinases. Trends Biochem Sci. 30:630–641. 2005.
View Article : Google Scholar : PubMed/NCBI
|
